[96a5a0]: / output / allTrials / identified / NCT02311101_identified.json

Download this file

226 lines (226 with data), 8.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
{
"info": {
"nct_id": "NCT02311101",
"official_title": "Sequential Intravesical Mitomycin Plus Bacillus Calmette-Guérin for Non-Muscle Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial",
"inclusion_criteria": "1. Newly diagnosed or recurrent multi-focal Ta, large Ta, high-grade Ta, CIS, or T1 bladder cancer\n2. In urologist's opinion a good candidate for BCG induction therapy\n3. Be able to give informed consent\n4. Be age 18 or older.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Inadequate marrow function (defined as granulocytes less than 1,500 cells/mm3 and platelets less than 150,000 cells/mm3)\n2. Immunosuppressed state (e.g. HIV, use of chronic steroids)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Newly diagnosed or recurrent multi-focal Ta, large Ta, high-grade Ta, CIS, or T1 bladder cancer",
"criterions": [
{
"exact_snippets": "Newly diagnosed or recurrent multi-focal Ta",
"criterion": "multi-focal Ta bladder cancer",
"requirements": [
{
"requirement_type": "diagnosis status",
"expected_value": [
"newly diagnosed",
"recurrent"
]
}
]
},
{
"exact_snippets": "large Ta",
"criterion": "large Ta bladder cancer",
"requirements": [
{
"requirement_type": "size",
"expected_value": "large"
}
]
},
{
"exact_snippets": "high-grade Ta",
"criterion": "high-grade Ta bladder cancer",
"requirements": [
{
"requirement_type": "grade",
"expected_value": "high-grade"
}
]
},
{
"exact_snippets": "CIS",
"criterion": "CIS bladder cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "T1 bladder cancer",
"criterion": "T1 bladder cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. In urologist's opinion a good candidate for BCG induction therapy",
"criterions": [
{
"exact_snippets": "In urologist's opinion a good candidate for BCG induction therapy",
"criterion": "BCG induction therapy candidacy",
"requirements": [
{
"requirement_type": "opinion",
"expected_value": "urologist's opinion"
}
]
}
]
},
{
"line": "3. Be able to give informed consent",
"criterions": [
{
"exact_snippets": "Be able to give informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "4. Be age 18 or older.",
"criterions": [
{
"exact_snippets": "age 18 or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Inadequate marrow function (defined as granulocytes less than 1,500 cells/mm3 and platelets less than 150,000 cells/mm3)",
"criterions": [
{
"exact_snippets": "Inadequate marrow function (defined as granulocytes less than 1,500 cells/mm3",
"criterion": "granulocytes",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 1500,
"unit": "cells/mm3"
}
}
]
},
{
"exact_snippets": "Inadequate marrow function ... platelets less than 150,000 cells/mm3",
"criterion": "platelets",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 150000,
"unit": "cells/mm3"
}
}
]
}
]
},
{
"line": "2. Immunosuppressed state (e.g. HIV, use of chronic steroids)",
"criterions": [
{
"exact_snippets": "Immunosuppressed state",
"criterion": "immunosuppressed state",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "HIV",
"criterion": "HIV",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "use of chronic steroids",
"criterion": "use of chronic steroids",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}